{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:11:05Z","timestamp":1792030265055,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.semarthrit.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T21:01:45Z","timestamp":1413493305000},"page":"e16-e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comment on \u201cAbsence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: A multicenter study of 689 patients\u201d"],"prefix":"10.1016","volume":"44","author":[{"given":"Pietro Enea","family":"Lazzerini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Leopoldo","family":"Capecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Boutjdir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Laghi-pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2014.10.002_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2014.07.001","article-title":"Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patients","author":"Massie","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.10.002_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/acr.20470","article-title":"Prolonged corrected QT interval in anti-Ro\/SSA-positive adults with systemic lupus erythematosus","volume":"63","author":"Bourr\u00e9-Tessier","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2014.10.002_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-3083.2010.02439.x","article-title":"Role of calcium channels in congenital heart block","volume":"72","author":"Karnabi","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.semarthrit.2014.10.002_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pharmthera.2008.02.001","article-title":"Pharmacological approach to the treatment of long and short QT syndromes","volume":"118","author":"Patel","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2014.10.002_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","article-title":"Transforming growth factor beta as a therapeutic target in systemic sclerosis","volume":"5","author":"Varga","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.10.002_bib6","doi-asserted-by":"crossref","first-page":"H622","DOI":"10.1152\/ajpheart.00781.2006","article-title":"Transforming growth factor-beta1 decreases cardiac muscle l-type Ca2+ current and charge movement by acting on the Cav1.2 mRNA","volume":"292","author":"Avila","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.semarthrit.2014.10.002_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/cvr\/cvs290","article-title":"Similar arrhythmicity in hypertrophic and fibrotic cardiac cultures caused by distinct substrate-specific mechanisms","volume":"97","author":"Askar","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.semarthrit.2014.10.002_bib8","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/acr.20540","article-title":"Anti-Ro\/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity","volume":"63","author":"Lazzerini","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2014.10.002_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-6-2","article-title":"Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis","volume":"6","author":"Parker","year":"2009","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.semarthrit.2014.10.002_bib10","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214002431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214002431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T08:56:42Z","timestamp":1538125002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017214002431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0049017214002431"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.10.002","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cAbsence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: A multicenter study of 689 patients\u201d","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}